10th European Tay-Sachs and Sandhoff Family Conference
The 10th European Tay-Sachs and Sandhoff Family Conference was held on the 29 – 30…
Read More27December
22December
Azafaros’ Phase 2 RAINBOW study, evaluating nizubaglustatin GM2 and NPC patients, is now fully enrolled
Azafaros’ Phase 2 RAINBOW study, evaluating nizubaglustatin GM2 and NPC patients, is now fully enrolled
Read More07August
Passage Bio announces promising interim clinical data from first right patient with GM1 Gangliosidosis in IMAGINE-1 study
PHILADELPHIA, Aug. 07, 2023 (GLOBE NEWSWIRE) — Passage Bio, Inc. (Nasdaq: PASG), a clinical-stage genetic…
Read More